Serial Number
87748380
Owner
GRITSTONE BIO, INC.Attorney
Shauna M. WertheimFirst Use Date
Mar 18, 2019
Filing Date
Jan 9, 2018
GRITSTONE Trademark
Serial Number: 87748380 • Registration: 6569577
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Shauna M. Wertheim The Marbury Law Group, PLLC
11800 Sunrise Valley Drive
15th Floor
Reston, VA 20191
United States
Trademark Details
Filing Date
January 9, 2018
Registration Date
November 23, 2021
First Use Anywhere
March 18, 2019
First Use in Commerce
March 18, 2019
Published for Opposition
August 21, 2018
Goods & Services
next-generation sequencing (NGS) data processor; bioinformatics data processor; downloadable computer software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry
pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; vaccines; vaccine preparations
healthcare
Providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer; conducting early evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services for others in the field of design, planning, and implementation of clinical trials; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice